Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(7%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_2
9
33%
Ph phase_1
15
56%
Ph not_applicable
1
4%
Ph phase_3
1
4%

Phase Distribution

15

Early Stage

9

Mid Stage

1

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
15(57.7%)
Phase 2Efficacy & side effects
9(34.6%)
Phase 3Large-scale testing
1(3.8%)
N/ANon-phased studies
1(3.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

2

trials recruiting

Total Trials

27

all time

Status Distribution
Active(3)
Completed(10)
Terminated(3)
Other(11)

Detailed Status

Completed10
unknown10
Withdrawn3
Recruiting2
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 115 (57.7%)
Phase 29 (34.6%)
Phase 31 (3.8%)
N/A1 (3.8%)

Trials by Status

recruiting27%
withdrawn311%
completed1037%
suspended14%
unknown1037%
not_yet_recruiting14%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT04565665Phase 1

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Recruiting
NCT07192211Phase 2

Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG

Not Yet Recruiting
NCT05939167Phase 1

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Recruiting
NCT05433298Phase 1

Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.

Withdrawn
NCT04522986Phase 1

An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection

Completed
NCT04888949Phase 2

A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

Completed
NCT03472742

An Follow-Up Study of Liver Cirrhosis

Completed
NCT03254758Phase 1

A Study of ADR-001 in Patients With Liver Cirrhosis

Completed
NCT02513238Phase 2

Mesenchymal Stemcells for Radiation Induced Xerostomia

Completed
NCT03362424Phase 2

Mesenchymal Stem Cells in Rotator Cuff Repair

Suspended
NCT02266394Phase 1

Hypoxia and Inflammatory Injury in Human Renovascular Hypertension

Completed
NCT04501354Phase 2

Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients

Unknown
NCT03164083Phase 2

The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis

Withdrawn
NCT03863002Phase 1

Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure

Unknown
NCT02344849Phase 1

Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction

Completed
NCT03209986Not Applicable

Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis

Unknown
NCT01716481Phase 3

The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study

Unknown
NCT02749448Phase 1

Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients

Unknown
NCT01504464Phase 2

The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis

Completed
NCT02116634Phase 1

Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis

Withdrawn

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
27